Bamlanivimab approved for high-risk COVID-19 patients
Category: Uncategorized
Merck, Eisai further complicate kidney cancer race with Keytruda-Lenvima win aliu Wed, 11/11/2020 – 10:41
Advocacy group launches campaign to hold newly elected politicians accountable on drug price promises bbulik Wed, 11/11/2020 – […]
Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID vaccine data lifts market arlene.weintraub Wed, […]
Amid cold chain blues, Pfizer looks to powder vaccine formula in 2021: report fkansteiner Wed, 11/11/2020 – 11:01
At any given moment in time, our brain is involved in various activities. As a result, brain signals […]
Sensors that monitor a patient’s condition during and after medical procedures can be expensive, uncomfortable and even dangerous. […]
Graded exercise therapy (GET) should no longer be offered for the treatment of chronic fatigue syndrome (CFS, also […]
Stokel-Walker says that telemedicine is “here to stay,”1 and it has some clear advantages, especially when it comes […]
